熱門資訊> 正文

Inovio Pharmaceuticals股价下跌6%，提议进行股权发行

2025-11-11 14:33

伊諾維奧製藥(INO) 0

Inovio Pharmaceuticals (INO) proposed an underwritten public offering of its common stock, with all shares in the offering to be sold by the company itself.
The underwriters have a 30-day option to purchase up to 15% additional shares.
The offering’s completion, size, and terms will depend on market conditions, and there is no guarantee as to its eventual execution or pricing.
The stock price traded ~6% lower on Tuesday during pre-market trade.

More on Inovio Pharmaceuticals

Inovio Pharmaceuticals, Inc. 2025 Q3 - Results - Earnings Call Presentation
Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (INO) Presents At H.C. Wainwright 27th Annual Global Investment Conference (Transcript)
Inovio outlines mid-2026 launch for INO-3107 as BLA submission progresses
Inovio Pharmaceuticals GAAP EPS of -$0.87 misses by $0.45

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。